{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:53:34Z","timestamp":1781837614162,"version":"3.54.5"},"reference-count":131,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.gassur.2004.04.010","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T11:17:41Z","timestamp":1096543061000},"page":"742-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Current management of gastrointestinal carcinoid tumors"],"prefix":"10.1016","volume":"8","author":[{"given":"Kenneth J.","family":"Woodside","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Courtney M.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.Mark","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.gassur.2004.04.010_BIB1","first-page":"229S","article-title":"Neuroendocrine embryology and the APUD concept","volume":"5","author":"Pearse","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.gassur.2004.04.010_BIB2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/1097-0142(196109\/10)14:5<901::AID-CNCR2820140502>3.0.CO;2-Q","article-title":"Life history of the carcinoid tumor of the small intestine","volume":"14","author":"Moertel","year":"1961","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF01966242","article-title":"Uber den pimaeren krebs des ileum nebst Bemerkungen ueber das gleichzeitige Vorkommen von krebs und Tuberculos","volume":"11","author":"Lubarsch","year":"1888","journal-title":"Virchows Arch"},{"key":"10.1016\/j.gassur.2004.04.010_BIB4","first-page":"425","article-title":"Karzinoide tumoren des dunndarms","volume":"1","author":"Oberndorfer","year":"1907","journal-title":"Frankf Z Pathol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM197902013000506","article-title":"Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature","volume":"300","author":"Roberts","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0016-5085(83)80122-X","article-title":"Histamine release from a gastric carcinoid: Provocation by pentagastrin and inhibition by somatostatin","volume":"84","author":"Roberts","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gassur.2004.04.010_BIB7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000007482","article-title":"Gastric carcinoid with histamine production, histamine transporter and expression of somatostatin receptors","volume":"59","author":"Kolby","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.gassur.2004.04.010_BIB8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1749-6632.1994.tb17289.x","article-title":"The human carcinoid cell line, BON. A model system for the study of carcinoid tumors","volume":"733","author":"Evers","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.gassur.2004.04.010_BIB9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1097-0142(197601)37:1<377::AID-CNCR2820370148>3.0.CO;2-L","article-title":"Gastric carcinoid with ectopic production of ACTH and beta-MSH","volume":"37","author":"Hirata","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-8703(54)90152-0","volume":"47","author":"Thorson","year":"1954","journal-title":"Am Heart J"},{"key":"10.1016\/j.gassur.2004.04.010_BIB11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9610(84)90470-7","article-title":"Silver stains and immunocytochemical analysis with monoclonal serotonin antibodies for liver metastases of endocrine tumors. A study on percutaneous biopsy specimens","volume":"148","author":"Lindgren","year":"1984","journal-title":"Am J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-0115(87)90029-2","article-title":"Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells","volume":"17","author":"Fiocca","year":"1987","journal-title":"Regul Pept"},{"key":"10.1016\/j.gassur.2004.04.010_BIB13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/1097-0142(19920715)70:2<513::AID-CNCR2820700223>3.0.CO;2-P","article-title":"Functioning ovarian carcinoids induce severe constipation","volume":"70","author":"Motoyama","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB14","first-page":"1452","article-title":"Somatostatinoma of the rectum","volume":"84","author":"Kitagawa","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB15","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/1097-0142(19811201)48:11<2409::AID-CNCR2820481112>3.0.CO;2-R","article-title":"Immunohistochemical evidence of peptide hormones in endocrine tumors of the rectum","volume":"48","author":"Alumets","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00000658-199110000-00009","article-title":"Expression of neurotensin messenger RNA in a human carcinoid tumor","volume":"214","author":"Evers","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","article-title":"An analysis of 8305 cases of carcinoid tumors","volume":"79","author":"Modlin","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB18","first-page":"322","article-title":"Carcinoid tumours. Frequency in a defined population during a 12-year period","volume":"84","author":"Berge","year":"1976","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"10.1016\/j.gassur.2004.04.010_BIB19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4","article-title":"Carcinoid tumors. An analysis of 2,837 cases","volume":"36","author":"Godwin","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archsurg.1983.01390040003001","article-title":"Surgical therapy for small-bowel carcinoid tumors","volume":"118","author":"Strodel","year":"1983","journal-title":"Arch Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB22","first-page":"427","article-title":"The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies","volume":"180","author":"Gerstle","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","article-title":"The classification of carcinoid tumours","volume":"1","author":"Williams","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2004.04.010_BIB24","series-title":"Sabiston Textbook of Surgery","first-page":"873","article-title":"Small bowel","author":"Evers","year":"2001"},{"key":"10.1016\/j.gassur.2004.04.010_BIB25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","article-title":"Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study","volume":"104","author":"Rindi","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gassur.2004.04.010_BIB26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/00000478-199006000-00001","article-title":"Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association","volume":"14","author":"Solcia","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB27","first-page":"353","article-title":"Carcinoids of the small intestine: A statistical evaluation of 1102 cases collected from the literature","volume":"16","author":"Soga","year":"1997","journal-title":"J Exp Clin Cancer Res"},{"issue":"Suppl 3","key":"10.1016\/j.gassur.2004.04.010_BIB28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000201197","article-title":"Revised classification of neuroendocrine tumors of the lung, pancreas and gut","volume":"55","author":"Capella","year":"1994","journal-title":"Digestion"},{"key":"10.1016\/j.gassur.2004.04.010_BIB29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002689900021","article-title":"Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions","volume":"20","author":"Kloppel","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000658-199906000-00008","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","volume":"229","author":"Shebani","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB31","first-page":"1054","article-title":"Carcinoid tumors of the gastrointestinal tract: Presentation, management, and prognosis","volume":"98","author":"Thompson","year":"1985","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB32","first-page":"68","article-title":"Carcinoid tumors: The relationship between clinical presentation and the extent of disease","volume":"110","author":"MacGillivray","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/02841869309083911","article-title":"Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors","volume":"32","author":"Eriksson","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB34","first-page":"1382","article-title":"False-negative fluorine-18-FDG PET in metastatic carcinoid","volume":"38","author":"Jadvar","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00006231-200208000-00005","article-title":"Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: Correlations with the pathological indexes p53 and Ki-67","volume":"23","author":"Belhocine","year":"2002","journal-title":"Nucl Med Commun"},{"issue":"Suppl 2","key":"10.1016\/j.gassur.2004.04.010_BIB36","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/annonc\/12.suppl_2.S41","article-title":"Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy","volume":"12","author":"Virgolini","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00259-002-1012-1","article-title":"PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide","volume":"30","author":"Wester","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.gassur.2004.04.010_BIB38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s002680010232","article-title":"Method for dissection of mesenteric metastases in mid-gut carcinoid tumors","volume":"24","author":"Ohrvall","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s002689900024","article-title":"Somatostatin receptor scintigraphy in patients with carcinoid tumors","volume":"20","author":"Kwekkeboom","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB40","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM199011013231805","article-title":"Somatostatin-receptor imaging in the localization of endocrine tumors","volume":"323","author":"Lamberts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1749-6632.1994.tb17291.x","article-title":"Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results","volume":"733","author":"Krenning","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.gassur.2004.04.010_BIB42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/02841869309096136","article-title":"Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide","volume":"32","author":"Westlin","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/qjmed\/91.4.295","article-title":"Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): A comparative study with CT and MR imaging","volume":"91","author":"Shi","year":"1998","journal-title":"Q J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiology.172.3.2772175","article-title":"Carcinoid tumors: Iodine-131 MIBG scintigraphy","volume":"172","author":"Hanson","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.gassur.2004.04.010_BIB45","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1210\/jcem.86.2.7194","article-title":"Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors","volume":"86","author":"Kaltsas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gassur.2004.04.010_BIB46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem-53-4-682","article-title":"Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor","volume":"53","author":"Leveston","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gassur.2004.04.010_BIB47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/jcem-60-3-423","article-title":"Immunohistological localization of growth hormone-releasing hormone in human tumors","volume":"60","author":"Asa","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gassur.2004.04.010_BIB48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0016-5085(76)80054-6","article-title":"Effect of serotonin on water and electrolyte transport in the in vivo rabbit small intestine","volume":"71","author":"Kisloff","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gassur.2004.04.010_BIB49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM199310073291503","article-title":"Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea","volume":"329","author":"von der Ohe","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB50","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/1097-0142(19841115)54:10<2273::AID-CNCR2820541036>3.0.CO;2-A","article-title":"Insular carcinoid of ovary associated with malignant mucinous tumors","volume":"54","author":"Robboy","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-5347(17)59887-0","article-title":"Primary argentaffinoma of the testis: A case report and survey of the literature","volume":"111","author":"Yalla","year":"1974","journal-title":"J Urol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-5347(17)66969-6","article-title":"Primary carcinoid tumor of the urethra","volume":"114","author":"Sylora","year":"1975","journal-title":"J Urol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1098-2388(199812)15:4<239::AID-SSU11>3.0.CO;2-4","article-title":"Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe","volume":"15","author":"Benevento","year":"1998","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB54","first-page":"745","article-title":"Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe","volume":"114","author":"Schirmer","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB55","first-page":"1139","article-title":"Detection of occult gastrinomas with iodine 125-labeled lanreotide and intraoperative gamma detection","volume":"116","author":"Woltering","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB56","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/bjs.1800810820","article-title":"Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection","volume":"81","author":"Ahlman","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB57","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(94)92925-4","article-title":"Use of fluid attenuated inversion recovery sequence in magnetic resonance imaging","volume":"344","author":"Hajnal","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2004.04.010_BIB58","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(94)92926-2","article-title":"Localisation of carcinoid tumour with radiolabelled octreotide and intraoperative gamma detection","volume":"344","author":"Dominioni","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2004.04.010_BIB59","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s002590100600","article-title":"Intraoperative tumour detection using 111In-DTPA-D-Phe1-octreotide and a scintillation detector","volume":"28","author":"Benjegard","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archsurg.136.1.49","article-title":"Treatment of gastric neuroendocrine tumors: The necessity of a type-adapted treatment","volume":"136","author":"Schindl","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB61","first-page":"1046","article-title":"Antrectomy for multicentric, argyrophil gastric carcinoids: A preliminary report","volume":"104","author":"Eckhauser","year":"1988","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB62","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0016-5085(92)90787-Y","article-title":"Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy","volume":"102","author":"Hirschowitz","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gassur.2004.04.010_BIB63","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002689900026","article-title":"Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior","volume":"20","author":"Rindi","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB64","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1091-255X(01)80100-1","article-title":"Duodenal carcinoid tumors: How aggressive should we be?","volume":"5","author":"Zyromski","year":"2001","journal-title":"J Gastrointest surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB65","first-page":"145","article-title":"A polyclonal antiserum against chromogranin A and B\u2014a new sensitive marker for neuroendocrine tumours","volume":"122","author":"Eriksson","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.gassur.2004.04.010_BIB66","first-page":"2622","article-title":"Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones","volume":"82","author":"Nobels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gassur.2004.04.010_BIB67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01658532","article-title":"Surgical treatment of mid-gut carcinoid tumors","volume":"14","author":"Makridis","year":"1990","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB68","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/BF02050937","article-title":"Gastrointestinal carcinoid tumors: Current management strategies","volume":"40","author":"Memon","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gassur.2004.04.010_BIB69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002689900028","article-title":"Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum","volume":"20","author":"Stinner","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00000658-199304000-00010","article-title":"Carcinoid tumors of the appendix","volume":"217","author":"Roggo","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB71","first-page":"1091","article-title":"Cytoreductive hepatic surgery for neuroendocrine tumors","volume":"108","author":"McEntee","year":"1990","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB72","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4","article-title":"Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group","volume":"77","author":"di Bartolomeo","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB73","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1572-0241.1998.00422.x","article-title":"A retrospective analysis of 1570 appendiceal carcinoids","volume":"93","author":"Sandor","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/1097-0142(196802)21:2<270::AID-CNCR2820210217>3.0.CO;2-9","article-title":"Carcinoid tumors of the vermiform appendix","volume":"21","author":"Moertel","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB75","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJM198712313172704","article-title":"Carcinoid tumor of the appendix: Treatment and prognosis","volume":"317","author":"Moertel","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB76","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumors","volume":"340","author":"Kulke","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1677\/erc.0.0100469","article-title":"Surgery for midgut carcinoid","volume":"10","author":"Sutton","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB78","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0002-9610(85)80184-7","article-title":"Carcinoid tumors of the colon. A study of 72 patients","volume":"149","author":"Rosenberg","year":"1985","journal-title":"Am J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB79","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/1097-0142(19920515)69:10<2400::AID-CNCR2820691003>3.0.CO;2-Z","article-title":"Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry","volume":"69","author":"Ballantyne","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000658-199001000-00012","article-title":"Anorectal carcinoid tumors. Is aggressive surgery warranted?","volume":"211","author":"Sauven","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bjs.1800740509","article-title":"Carcinoid tumours of the rectum and anus","volume":"74","author":"Burke","year":"1987","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB82","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1294::AID-CNCR4>3.0.CO;2-H","article-title":"Carcinoid tumors of the rectum: Effect of size, histopathology, and surgical treatment on metastasis free survival","volume":"79","author":"Koura","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB83","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s002689900138","article-title":"Metastatic endocrine tumors: Medical treatment, surgical resection, or liver transplantation","volume":"20","author":"Dousset","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB84","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7326\/0003-4819-120-4-199402150-00008","article-title":"The management of patients with advanced carcinoid tumors and islet cell carcinomas","volume":"120","author":"Moertel","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9610(99)80107-X","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas","volume":"169","author":"Que","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB86","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB87","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/000313480206800803","article-title":"Cytoreductive surgery in patients with advanced-stage carcinoid tumors","volume":"68","author":"Gulec","year":"2002","journal-title":"Am Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB88","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","article-title":"Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases","volume":"26","author":"Hellman","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB89","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.surg.2003.07.025","article-title":"Aggressive surgery for metastatic liver neuroendocrine tumors","volume":"134","author":"Norton","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.gassur.2004.04.010_BIB90","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1677\/erc.0.0100463","article-title":"Ablative therapies for liver metastases of digestive endocrine tumours","volume":"10","author":"O'Toole","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjsurg.2003.04.007","article-title":"Management of neuroendocrine liver metastases","volume":"187","author":"Sutcliffe","year":"2004","journal-title":"Am J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB92","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000658-199704000-00002","article-title":"Liver transplantation for metastatic neuroendocrine tumors","volume":"225","author":"Lang","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB93","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199704000-00003","article-title":"Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report","volume":"225","author":"Le Treut","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB94","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/bja\/87.3.447","article-title":"Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours","volume":"87","author":"Kinney","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.gassur.2004.04.010_BIB95","first-page":"327","article-title":"Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome","volume":"2","author":"Moertel","year":"1979","journal-title":"Cancer Clin Trials"},{"key":"10.1016\/j.gassur.2004.04.010_BIB96","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1200\/JCO.1984.2.11.1255","article-title":"Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor","volume":"2","author":"Engstrom","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB97","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1097-0142(19871215)60:12<2891::AID-CNCR2820601207>3.0.CO;2-6","article-title":"A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study","volume":"60","author":"Bukowski","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB98","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.2002.01589.x","article-title":"Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil","volume":"57","author":"Kaltsas","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.gassur.2004.04.010_BIB99","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0360-3016(91)90061-8","article-title":"The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors","volume":"20","author":"Schupak","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.gassur.2004.04.010_BIB100","first-page":"79","article-title":"The clinical use of gastrointestinal hormones for alimentary tract disease","volume":"29","author":"Townsend","year":"1996","journal-title":"Adv Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB101","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00000658-199103000-00002","article-title":"Somatostatin and analogues in the treatment of cancer. A review","volume":"213","author":"Evers","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB102","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB103","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1572-0241.1998.465_q.x","article-title":"Slow-release lanreotide treatment in endocrine gastrointestinal tumors","volume":"93","author":"Tomassetti","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB104","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1999.17.2.600","article-title":"Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome","volume":"17","author":"Rubin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2036.2003.01420.x","article-title":"Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: A 3-year experience","volume":"17","author":"Garland","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gassur.2004.04.010_BIB106","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1445-2197.2002.02507.x","article-title":"Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours","volume":"72","author":"Rohaizak","year":"2002","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB107","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0959-8049(01)00073-9","article-title":"Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours","volume":"37","author":"Aparicio","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB108","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1080\/02841860310010547","article-title":"Carcinoid\u2014a comprehensive review","volume":"42","author":"Schnirer","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02841869309083916","article-title":"Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon","volume":"32","author":"Janson","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB110","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0959-8049(92)90060-F","article-title":"Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours","volume":"28A","author":"Tiensuu Janson","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gassur.2004.04.010_BIB111","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/bjs.4149","article-title":"Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours","volume":"90","author":"Kolby","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB112","first-page":"1381","article-title":"Combination therapy with octreotide and alpha-interferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors","volume":"94","author":"Frank","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB113","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00000658-199105000-00005","article-title":"Novel therapy for the treatment of human carcinoid","volume":"213","author":"Evers","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB114","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/B:DRUG.0000006177.46798.1f","article-title":"Phase II study of interferon gamma in malignant carcinoid tumors (E9292): A trial of the Eastern Cooperative Oncology Group","volume":"22","author":"Stuart","year":"2004","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.gassur.2004.04.010_BIB115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/02841869309083917","article-title":"Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial","volume":"32","author":"Janson","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB116","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(05)78355-0","article-title":"Yttrium-90-labelled somatostatin-analogue for cancer treatment","volume":"351","author":"Otte","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.gassur.2004.04.010_BIB117","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.1996.14.6.1829","article-title":"Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors","volume":"14","author":"Taal","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB118","first-page":"1","article-title":"Long-term efficacy of high-activity 111in-pentetreotide therapy in patients with disseminated neuroendocrine tumors","volume":"44","author":"Buscombe","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB119","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1023\/A:1011160913619","article-title":"The clinical value of [90Y-DOTA]-D-Phe1Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study","volume":"12","author":"Waldherr","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB120","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/ejso.2001.1132","article-title":"(131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome","volume":"27","author":"Pathirana","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB121","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/bjs.4069","article-title":"111In-labelled octreotide binding by the somatostatin receptor subtype 2 in neuroendocrine tumours","volume":"90","author":"Hashemi","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2004.04.010_BIB122","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.gassur.2004.04.010_BIB123","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1021\/jm0302445","article-title":"Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8","volume":"46","author":"Erchegyi","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.gassur.2004.04.010_BIB124","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1073\/pnas.250483897","article-title":"SST3-selective potent peptidic somatostatin receptor antagonists","volume":"97","author":"Reubi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gassur.2004.04.010_BIB125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(02)02651-1","article-title":"A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors","volume":"456","author":"Reubi","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB126","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00001622-200201000-00010","article-title":"Somatostatin and somatostatin analogues: Diagnostic and therapeutic uses","volume":"14","author":"de Herder","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.gassur.2004.04.010_BIB127","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocrinol Rev"},{"key":"10.1016\/j.gassur.2004.04.010_BIB128","first-page":"3048s","article-title":"Targeting strategies for cancer radiotherapy","volume":"5","author":"Buchsbaum","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gassur.2004.04.010_BIB129","first-page":"1139","article-title":"Bombesin receptor subtypes in human cancers: Detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14)","volume":"8","author":"Reubi","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gassur.2004.04.010_BIB130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: Molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.gassur.2004.04.010_BIB131","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1067\/msy.1998.91830","article-title":"A novel cytotoxic agent for human carcinoid tumors","volume":"124","author":"Litvak","year":"1998","journal-title":"Surgery"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X04001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X04001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:22:41Z","timestamp":1761074561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X04001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1091255X04001805"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2004.04.010","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current management of gastrointestinal carcinoid tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2004.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}